DEF 14A: Pyxus International Sets Date for Virtual Annual Shareholder Meeting, Proposes Director Elections and Incentive Plan Approval

Sentiment:

Proxy Statement


Pyxus International will hold its annual shareholder meeting virtually on August 15, 2024, to vote on director elections, auditor ratification, executive compensation, and an amended incentive plan.

Summary

  • Pyxus International, Inc. will hold its 2024 Annual Meeting of Shareholders virtually on August 15, 2024, at 10:00 a.m. Eastern Daylight Time.
  • Shareholders of record as of June 14, 2024, are entitled to vote.
  • The meeting will address the election of seven directors, ratification of Deloitte & Touche LLP as independent auditors for the fiscal year ending March 31, 2025, an advisory vote on executive compensation, and approval of the Amended and Restated 2020 Incentive Plan.
  • The Board of Directors recommends voting for all director nominees, ratification of the auditor, approval of executive compensation, and approval of the Amended and Restated Incentive Plan.
  • The proxy statement and 2024 Annual Report are available online.
  • The company is soliciting proxies and will bear the cost of solicitation.
  • The Board has nominated John S. Alphin, Jamie J. Ashton, Patrick J. Bartels, Jr., Robert D. George, Cynthia P. Moehring, J. Pieter Sikkel, and Richard J.C. Topping for election as directors.
  • The Amended and Restated Incentive Plan seeks shareholder approval to increase the number of shares authorized for issuance from 2,200,000 to 3,220,000.
  • The company has adopted policies prohibiting directors and executive officers from engaging in hedging or pledging activities with respect to the company's securities.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, presenting information in a neutral and factual manner. The sentiment is moderately positive as it reflects the company's efforts to engage with shareholders and maintain good corporate governance practices.

Positives

  • The company is providing shareholders with a virtual meeting option for increased accessibility.
  • The Board is actively engaged in corporate governance, including risk oversight and ethical standards.
  • The company has a clear Code of Business Conduct and Corporate Governance Guidelines.
  • The company is seeking shareholder input on key decisions, including executive compensation and the incentive plan.
  • The company has policies in place to prevent hedging and pledging of company stock by directors and executive officers, aligning their interests with shareholders.

Negatives

  • The company's common stock is traded on the OTC Pink Bulletin Board, which has less stringent listing requirements than national exchanges.
  • The company's Amended and Restated Articles of Incorporation provide that the chairperson of the Board of Directors shall be elected by a majority of the Glendon Directors and the Monarch Directors, each acting in his or her sole discretion; provided, that if the number of Glendon Directors plus the number of Monarch Directors is fewer than three or if no such majority can be reached, then the chairperson of the Board of Directors is to be elected by a majority of the Directors then in office.
  • The company's Amended and Restated Articles of Incorporation provide that the membership of committees of the Board of Directors of the Company include a Glendon Director and a Monarch Director if requested by the Glendon Investor and the Monarch Investor, respectively.

Risks

  • The company faces various risks, including credit, liquidity, operational, regulatory, and environmental risks, as disclosed in public filings.
  • The company's success depends on attracting, motivating, and retaining qualified executive talent.
  • The company's performance is subject to market conditions and the tobacco industry's regulatory environment.
  • The company's Amended and Restated Incentive Plan may not be approved by shareholders, potentially affecting the treatment of stock options and future grants.

Future Outlook

The company aims to attract, motivate, and retain qualified executive talent to provide strong leadership and align their interests with shareholders, supporting a pay-for-performance culture and maintaining a cost-effective structure.

Industry Context

The announcement reflects standard corporate governance practices, including shareholder voting on key matters like director elections and executive compensation, which are common in publicly held companies.

Comparison to Industry Standards

  • The company's director compensation structure, including cash retainers and equity awards, is generally in line with industry practices for companies of similar size and complexity.
  • The company's executive compensation program, including base salary, annual incentives, and long-term equity awards, is designed to align executive pay with company performance and shareholder value creation, consistent with industry norms.
  • The company's corporate governance practices, such as having a Code of Business Conduct and independent directors on key committees, are consistent with best practices for publicly traded companies.

Related Party Transactions

  • On March 21, 2024, Pyxus Holdings, Inc., a wholly owned subsidiary of the Company (Pyxus Holdings), entered into an agreement (the Debt Repurchase Agreement) with funds affiliated with the Monarch Investor and of which the Monarch Investor is the investment advisor (collectively, the Monarch Funds).
  • Under the Debt Repurchase Agreement, Pyxus Holdings agreed to purchase from the Monarch Funds approximately $77.9 million aggregate principal amount of its 8.50% Senior Secured Notes due December 31, 2027 (the 2027 Notes) for approximately $60.0 million, a 23.0% discount to par value, plus accrued and unpaid interest and specified customary fees.
  • The Debt Repurchase Agreement also included the right of Pyxus Holdings, at its option, to purchase from the Monarch Funds an additional approximately $34.2 million aggregate principal amount of 2027 Notes for approximately $26.3 million, a 23.0% discount to par value, and, for approximately $9.1 million, at a 12.0% discount to par value, approximately $10.3 million aggregate principal amount of loans (the Pyxus Term Loans) outstanding under the Pyxus Term Loan Credit Agreement, dated as of February 6, 2023, by and among, Pyxus Holdings, the guarantors party thereto, the lenders party thereto and Alter Domus (US) LLC, as administrative agent and senior collateral agent, plus, in each case, accrued and unpaid interest and specified customary fees.
  • The purchase of the approximately $77.9 million aggregate principal amount of the 2027 Notes pursuant to the Debt Repurchase Agreement was completed on March 28, 2024, resulting in a payment by Pyxus Holdings to the Monarch funds of approximately $62.3 million, which includes accrued interest and fees.
  • On April 12, 2024, Pyxus Holdings exercised its right under the Debt Repurchase Agreement to purchase such additional approximately $34.2 million aggregate principal amount of 2027 Notes and approximately $10.3 million aggregate principal amount of the Pyxus Term Loans.
  • On May 31, 2024, a total of approximately $9.4 million was paid to retire approximately $10.3 million of aggregate principal amount of the Pyxus Term Loans, and included payment for accrued and unpaid interest through the day prior to payment and specified customary fees.
  • Certain funds managed by Glendon Capital Management LP, Monarch Alternative Capital LP, Owl Creek Investment Management L.P. and CI Investments Inc. (the Investor-Affiliated Funds) hold debt instruments and loans issued by Pyxus Holdings and guaranteed by Pyxus and certain of its subsidiaries.
  • Interest expense accrued by the Company and its subsidiaries in the fiscal year ended March 31, 2024 with respect to such debt instruments and loans held by the Investor-Affiliated Funds was an aggregate of approximately $40.9 million, which includes interest on the 2027 Notes purchased pursuant to the Debt Repurchase Agreement through the date of purchase.
  • Mr. Sikkels adult daughter, Kim Sikkel, is employed as Operations Manager of the Companys AOSP Investments, LLC subsidiary, which holds the Companys interests in its e-liquids businesses.
  • Ms. Sikkels total compensation in the fiscal year ended March 31, 2024, consisting of salary, annual bonus, employer 401k plan contribution and premiums on employer-paid life insurance, was $136,759.

Stakeholder Impact

  • Shareholders have the opportunity to influence company decisions through voting on key proposals.
  • Employees may be affected by changes to the incentive plan and executive compensation.
  • The company's performance and governance practices can impact its relationships with customers, suppliers, and creditors.

Next Steps

  • Shareholders are encouraged to vote on the proposals outlined in the proxy statement.
  • The company will publish final voting results in a report on Form 8-K to be filed with the SEC within four business days after the annual meeting.

Key Dates

DateDescription
August 24, 2020Company entered into a Shareholders Agreement in connection with the resolution of Chapter 11 bankruptcy proceedings.
August 24, 2020Effective date of the plan of reorganization confirmed in the Chapter 11 Cases.
August 19, 2021Shareholders approved the Incentive Plan at the annual meeting.
March 31, 2024Fiscal year ended.
March 21, 2024Board of Directors adopted the Amended and Restated Incentive Plan.
June 14, 2024Record date for determining shareholders entitled to vote at the annual meeting.
July 12, 2024Proxy statement and 2024 Annual Report first mailed to shareholders.
August 8, 2024Deadline for registering legal proxy with Equiniti to vote online at the virtual annual meeting (5:00 p.m. Eastern Daylight Time).
August 15, 2024Date of the 2024 Annual Meeting of Shareholders (10:00 a.m. Eastern Daylight Time).
March 14, 2025Deadline for shareholder proposals to be included in the company's proxy statement for the 2025 annual meeting.
April 17, 2025Deadline for shareholder nominations for the 2025 annual meeting.
April 17, 2025Deadline for shareholder proposals to be brought before the 2025 annual meeting.

Keywords

shareholders, directors, compensation, incentive plan, governance, pyxus, voting, auditors, meeting, stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.